OS Therapies Incorporated (OSTX)Healthcare | Biotechnology | Grasonville, United States | NYSE American
1.64 USD
-0.04
(-2.381%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.64 |
Hot Take ↕ | Aug. 22, 2026, 6:04 a.m. EDT
The immediate outlook is severely clouded by a sharp technical breakdown and deteriorating liquidity. After trading near $1.63, the stock collapsed to $1.44 within a week, signaling a loss of momentum and buyer interest. This weakness is compounded by a massive gap between the current price and the consensus analyst target of nearly $9, suggesting the market views the current valuation as disconnected from the company's potential. Fundamentally, the business is in distress: the balance sheet is fragile with a current ratio of just 0.05, indicating severe liquidity constraints, while operating cash flow is deeply negative. Although the company recently raised capital and released promising bone cancer data, these positives are insufficient to offset the structural financial weaknesses and the brutal 38% annual price decline. There is no dividend to provide income, and the statistical models offer no reliable short-term edge given the low confidence scores and recent volatility. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.108438 |
| AutoETS | 0.128350 |
| AutoARIMA | 0.130868 |
| MSTL | 0.142936 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 27% |
| H-stat | 0.80 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 4.38 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 76,212,096 |
| Forward P/E | 5.07 |
| Beta | -0.73 |
| Previous Name | EXENO |
| Website | https://ostherapies.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.24324322 |
| Address1 | 115 Pullman Crossing Road |
| Address2 | Suite 103 |
| All Time High | 7.0 |
| All Time Low | 1.12 |
| Ask | 1.63 |
| Ask Size | 400 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 447,340 |
| Average Daily Volume3 Month | 595,891 |
| Average Volume | 595,891 |
| Average Volume10Days | 447,340 |
| Beta | -0.729 |
| Bid | 1.63 |
| Bid Size | 1,000 |
| Book Value | -0.263 |
| City | Grasonville |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.64 |
| Current Ratio | 0.176 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.69 |
| Day Low | 1.6 |
| Display Name | OS Therapies |
| Earnings Timestamp | 1,786,969,800 |
| Earnings Timestamp End | 1,794,832,200 |
| Earnings Timestamp Start | 1,794,832,200 |
| Ebitda | -37,111,284 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -2.062 |
| Enterprise Value | 76,512,024 |
| Eps Current Year | -0.675 |
| Eps Forward | 0.32333 |
| Eps Trailing Twelve Months | -1.06 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.6392 |
| Fifty Day Average Change | 0.00080001354 |
| Fifty Day Average Change Percent | 0.0004880512 |
| Fifty Two Week Change Percent | -24.324322 |
| Fifty Two Week High | 2.36 |
| Fifty Two Week High Change | -0.7199999 |
| Fifty Two Week High Change Percent | -0.30508474 |
| Fifty Two Week Low | 1.15 |
| Fifty Two Week Low Change | 0.49 |
| Fifty Two Week Low Change Percent | 0.42608696 |
| Fifty Two Week Range | 1.15 - 2.36 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,722,519,000,000 |
| Float Shares | 37,795,501 |
| Forward Eps | 0.32333 |
| Forward P E | 5.0722175 |
| Free Cashflow | -1,689,954 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 4 |
| Fullday Change | -0.04 |
| Fullday Change Percent | -2.38095 |
| Fullday Price | 1.64 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.21215001 |
| Held Percent Institutions | 0.06254 |
| Implied Shares Outstanding | 46,470,790 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland. |
| Long Name | OS Therapies Incorporated |
| Market | us_market |
| Market Cap | 76,212,096 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_580518990 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-29 |
| Net Income To Common | -39,369,580 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 78,070,927 |
| Number Of Analyst Opinions | 5 |
| Open | 1.69 |
| Operating Cashflow | -18,532,848 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 410 297 7793 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 1.64 |
| Post Market Time | 1,787,961,435 |
| Prev Name | EXENO |
| Previous Close | 1.68 |
| Price Eps Current Year | -2.4296296 |
| Price Hint | 4 |
| Price To Book | -6.235741 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.16 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.25 |
| Region | US |
| Regular Market Change | -0.04 |
| Regular Market Change Percent | -2.38095 |
| Regular Market Day High | 1.69 |
| Regular Market Day Low | 1.6 |
| Regular Market Day Range | 1.6 - 1.69 |
| Regular Market Open | 1.69 |
| Regular Market Previous Close | 1.68 |
| Regular Market Price | 1.64 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 291,820 |
| Return On Assets | -2.32652 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 46,470,790 |
| Shares Percent Shares Out | 0.055999998 |
| Shares Short | 2,583,033 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 2,633,212 |
| Short Name | OS Therapies Incorporated |
| Short Percent Of Float | 0.060300004 |
| Short Ratio | 8.14 |
| Source Interval | 15 |
| State | MD |
| Symbol | OSTX |
| Target High Price | 13.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 8.918 |
| Target Median Price | 8.0 |
| Total Cash | 205,035 |
| Total Cash Per Share | 0.004 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.06 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.58855 |
| Two Hundred Day Average Change | 0.051450014 |
| Two Hundred Day Average Change Percent | 0.032388035 |
| Type Disp | Equity |
| Volume | 291,820 |
| Website | https://ostherapies.com |
| Zip | 21,638 |